Symbol Insights

You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.

Insights for Amgen Inc.
NASDAQ: AMGN
05 - Growing & Profitable but Heavily Leveraged
Sector: Health & Fitness
Industry: Medicine - Production & Distribution
Today's Price
updated on: 		293.54 (-1.42%)
Open 299.16 (-1.88%)
High (Upside %) 299.61 (2.07%)
Low (Downside %) 292.58 (0.33%)
P. Close 297.78 (-1.42%)
Open-High % 0.15%
Open-Low % 2.2%
Low-High % 2.4%
Active Buy Quantity 0
Active Sell Quantity 0
% Overtraded
Current Mood bearish
Previous Data
data from:
Open-High % 0.15%
Open-Low % 2.2%
Low-High % 2.4%
Open-Close % -1.88%
Low-Close % 0.33%
High-Close % 2.03%

AMGN is a Stock listed in the US on the NASDAQ under the ticker 'AMGN'

Company Profile

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

source:https://finance.yahoo.com/AMGN/profile

Predicted Prices
Key Low (open) Low (high) Close-Down (open) Close-Down (high) Close-Up (open) Close-Up (low) High (open) High (low)
Low Volatility 298.33
45.03% hit 		295.39
54.71% hit 		296.44
16.45% hit 		298.91
44.69% hit 		300.47
15.25% hit 		293.23
46.42% hit 		300.69
42.71% hit 		296.76
54.71% hit
Average Volatility 295.11
31.7% hit 		291.64
36.47% hit 		293.03
14.99% hit 		295.66
31.37% hit 		304.75
13.33% hit 		297.48
31.17% hit 		305.18
29.77% hit 		300.58
36.47% hit
High Volatility 283.55
3.98% hit 		279.18
3.12% hit 		285.41
3.51% hit 		285.41
3.85% hit 		316.86
3.91% hit 		313.08
4.11% hit 		317.26
3.32% hit 		314.0
3.12% hit

AMGN's predicted prices using open from of 299.16 and data until date . Current Price is 293.54

Basic Stats
Market Cap-Display Market Cap-Actual Market Cap Enterprise Value-Display Enterprise Value-Actual Enterprise Value Trailing P/E Forward P/E PEG Ratio (5yr expected) Price/Sales Price/Book Enterprise Value/Revenue Enterprise Value/EBITDA Profit Margin Operating Margin Return on Assets Return on Equity Revenue-Display Revenue-Actual Revenue Quarterly Revenue Growth EBITDA-Display EBITDA-Actual EBITDA Diluted EPS Quarterly Earnings Growth Total Cash-Display Total Cash-Actual Total Cash Total Debt-Display Total Debt-Actual Total Debt Total Debt/Equity Current Ratio Operating Cash Flow-Display Operating Cash Flow-Actual Operating Cash Flow Levered Free Cash Flow-Display Levered Free Cash Flow-Actual Levered Free Cash Flow % Held by Insiders % Held by Institutions
150.67 B 150670000000.0 150.67 202.06 B 202060000000.0 202.06 35.8 13.46 1.99 4.65 20.02 6.21 14.99 13.00% 24.16% 4.60% 55.72% 32.53 B 32530000000.0 32.53 23.20% 12.25 B 12250000000.0 12.25 7.82 63.60% 9.01 B 9010000000.0 9.01 60.4 B 60400000000.0 60.4 8.0242 1.32 7.26 B 7260000000.0 7.26 4.57 B 4570000000.0 4.57 0.21% 80.71%

source:https://finance.yahoo.com/AMGN/key-statistics

Reading Information

source:https://finance.yahoo.com/AMGN/key-statistics

source:https://www.google.com/finance/quote/AMGN:NASDAQ

source:https://finance.yahoo.com/AMGN/analysis

source:https://finance.yahoo.com/AMGN/fair-value

Upside-Downside Spread
Key Weighted 5D 1M 3M 6M 1Y 3Y 10Y
Upside % (high) 8.51% 5.43% (309.49) 5.43% (309.49) 11.82% (328.25) 16.13% (340.89) 18.16% (346.85) 18.16% (346.85) 18.16% (346.85)
Downside % (low) 10.36% 3.45% (283.4) 11.65% (259.3537) 13.71% (253.3) 13.71% (253.3) 13.71% (253.3) 27.88% (211.71) 55.68% (130.09)
Spread % -1.85% 1.98% -6.21% -1.88% 2.42% 4.45% -9.72% -37.52%

AMGN's price used for computing the stats is 293.54 as on date

Cumulative Return Percent
Key Today 5D 1M 3M 6M 1Y 3Y 10Y
Last Price-Trend PrevClose 0.0% 2.84% 13.52% -8.31% -11.92% -7.13% 28.22% 92.49%
Last Price 293.54 293.54 293.54 293.54 293.54 293.54 293.54 293.54
Trend-Previous Close 293.54 285.42 258.59 320.16 333.28 316.07 228.93 152.5

AMGN's symbol cumulative return percent is computed basis data from date

Return Velocity
5D 2W 1M 3M 6M 1Y
5D window
Metric Mean Median Stdev
Overall 4.43% 3.11% 2.89%
Up 6.14% 7.84% 3.29%
Down -0.19% 0% 0.42%
5D Opportunity:
returns: 2.84% (9.43%), p.close: 285.42
entry: 312.34, exit: 302.54, return: 3.14%
Metric Mean Median Stdev
Overall 3.7% 3.06% 2.15%
Up 4.7% 3.55% 2.71%
Down -0.23% 0% 0.39%
5D Opportunity:
returns: 2.84% (7.41%), p.close: 285.42
entry: 306.56, exit: 300.31, return: 2.04%
Metric Mean Median Stdev
Overall 2.97% 2.74% 1.71%
Up 3.61% 3.12% 2.18%
Down -0.3% 0% 0.41%
5D Opportunity:
returns: 2.84% (5.79%), p.close: 285.42
entry: 301.94, exit: 298.1, return: 1.27%
Metric Mean Median Stdev
Overall -0.46% -0.03% 4.02%
Up 1.86% 1.29% 2.07%
Down -2.22% -0.97% 2.96%
5D Opportunity: SELL-APPROACHING
returns: 2.84% (3.93%), p.close: 285.42
entry: 296.64, exit: 296.8, return: -0.05%
Metric Mean Median Stdev
Overall -0.41% -0.18% 3.22%
Up 1.48% 1.07% 1.69%
Down -1.98% -0.94% 2.56%
5D Opportunity: SELL-APPROACHING
returns: 2.84% (3.17%), p.close: 285.42
entry: 294.46, exit: 294.1, return: 0.12%
Metric Mean Median Stdev
Overall -0.1% -0.18% 3.58%
Up 1.76% 1.1% 2.36%
Down -1.87% -1.07% 2.34%
5D Opportunity: SELL-APPROACHING
returns: 2.84% (4.12%), p.close: 285.42
entry: 297.19, exit: 295.11, return: 0.7%
2W window
Metric Mean Median Stdev
Overall 6.63% 6.05% 2.38%
Up 7.65% 6.05% 2.94%
Down -0.25% 0% 0.43%
2W Opportunity:
returns: 6.58% (10.6%), p.close: 275.42
entry: 304.6, exit: 298.62, return: 1.96%
Metric Mean Median Stdev
Overall 4.66% 5.19% 2.98%
Up 5.37% 5.19% 3.31%
Down -0.68% -0.39% 0.77%
2W Opportunity: SELL-APPROACHING
returns: 6.58% (8.68%), p.close: 275.42
entry: 299.32, exit: 297.91, return: 0.47%
Metric Mean Median Stdev
Overall -1.26% -1.47% 5.51%
Up 2.63% 1.86% 2.95%
Down -3.76% -2.17% 4.02%
2W Opportunity: SELL-ACTIVE
returns: 6.58% (5.58%), p.close: 275.42
entry: 290.78, exit: 286.56, return: 1.45%
Metric Mean Median Stdev
Overall -0.99% -0.68% 4.33%
Up 2.09% 1.52% 2.33%
Down -3.29% -2.1% 3.34%
2W Opportunity: SELL-ACTIVE
returns: 6.58% (4.42%), p.close: 275.42
entry: 287.6, exit: 285.48, return: 0.74%
Metric Mean Median Stdev
Overall -0.22% -0.37% 5.05%
Up 2.8% 1.85% 3.37%
Down -3.02% -2.18% 3.03%
2W Opportunity: SELL-ACTIVE
returns: 6.58% (6.18%), p.close: 275.42
entry: 292.43, exit: 288.31, return: 1.41%
1M window
Metric Mean Median Stdev
Overall 4.64% 5.81% 6.77%
Up 6.37% 6.68% 6.18%
Down -2.96% -2.14% 2.4%
1M Opportunity: SELL-ACTIVE
returns: 13.52% (12.55%), p.close: 258.59
entry: 291.04, exit: 291.14, return: -0.03%
Metric Mean Median Stdev
Overall -4.16% -6.67% 8.31%
Up 3.29% 1.89% 4.31%
Down -7.4% -7.57% 4.94%
1M Opportunity: SELL-ACTIVE
returns: 13.52% (7.6%), p.close: 258.59
entry: 278.24, exit: 262.83, return: 5.54%
Metric Mean Median Stdev
Overall -2.35% -2.17% 6.53%
Up 3.0% 2.23% 3.46%
Down -5.66% -5.47% 4.25%
1M Opportunity: SELL-ACTIVE
returns: 13.52% (6.46%), p.close: 258.59
entry: 275.29, exit: 269.86, return: 1.97%
Metric Mean Median Stdev
Overall -0.66% -1.87% 7.58%
Up 4.64% 3.17% 5.03%
Down -5.0% -4.6% 3.98%
1M Opportunity: SELL-ACTIVE
returns: 13.52% (9.67%), p.close: 258.59
entry: 283.61, exit: 273.36, return: 3.61%

AMGN's symbol current price is 293.54 (0.0%) as on . Yesterday's close was 293.54. It's return velocities are computed basis data from date .

Win Percent
Key Weighted 5D 1M 3M 6M 1Y 3Y
Open-High (> 1.0%) 44.23% 40.0% 54.55% 40.91% 36.36% 38.89% 34.79%
Open-Low (> 1.0%) 44.36% 60.0% 27.27% 42.42% 36.36% 37.3% 37.96%
Open-Close-Up (> 0.5%) 51.23% 60.0% 54.55% 37.88% 34.09% 32.54% 30.69%
Open-Close-Down (> 0.5%) 31.19% 40.0% 18.18% 33.33% 29.55% 32.54% 30.95%
Low-Close-Up (> 1.0%) 50.84% 60.0% 45.45% 45.45% 42.42% 39.29% 40.74%
High-Close-Down (> 1.0%) 36.8% 40.0% 31.82% 37.88% 36.36% 37.7% 36.51%

AMGN's symbol win percent is computed basis data from date

Associated Tags